U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TGN-1412
POO0DOD3AS
Investigational
General
Record Details
Names
6
Identifiers
3
Relationships
1
Active Moiety
1
Characteristic Attributes
2
TGN-1412
POO0DOD3AS
Investigational
General
Approval Year
Unknown
139,594
Record Details
Substance Class
Protein
Protein Type
MONOCLONAL ANTIBODY
Protein Sub Type
IGG4
Sequence Origin
HUMANIZED MOUSE
Sequence Type
COMPLETE
Record UNII
POO0DOD3AS
Record Status
Validated (UNII)
Record Version
8
7
6
5
4
3
2
1
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TGN-1412
Common Name
English
TGN1412
Common Name
English
TAB-08
Code
English
Theralizumab [WHO-DD]
Common Name
English
THERALIZUMAB
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
3
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
906068-56-2
PRIMARY
WIKIPEDIA
Theralizumab
PRIMARY
FDA UNII
POO0DOD3AS
PRIMARY
Showing 1 to 3 of 3 entries
Previous
1
Next
Relationships
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
F05Y5QQX44
T-CELL-SPECIFIC SURFACE GLYCOPROTEIN CD28
TARGET -> AGONIST
Comments:
Superagonist LED TO CYTOKINE STORM
Showing 1 to 1 of 1 entries
Previous
1
Next
Active Moiety
1
Show
5
20
100
All
entries
Related Record
Type
Details
Related Record
Type
Details
POO0DOD3AS
TGN-1412
ACTIVE MOIETY
Showing 1 to 1 of 1 entries
Previous
1
Next
Characteristic Attributes
2
Show
5
20
100
All
entries
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Name
Property Type
Amount
Referenced Substance
Defining
Parameters
References
Molecular Formula
CHEMICAL
ESTIMATED
MOL_WEIGHT:NUMBER(CALCULATED)
CHEMICAL
ESTIMATED
Showing 1 to 2 of 2 entries
Previous
1
Next
